Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema

Clinical trial NCT04991350 · TERMINATED

Trial details

NCT number: NCT04991350
Sponsor: Cairo University
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Macular Edema Macular Ischemia Diabetic Retinopathy Vascular Endothelial Growth Factor Overexpression

Start date: 2021-11-26
Primary completion: 2022-09-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.